# Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology

> **NIH NIH K12** · MASSACHUSETTS GENERAL HOSPITAL · 2020 · $959,799

## Abstract

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
Project Summary/Abstract
The goal of the Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
(DF/HCC K12) is to prepare the next generation of clinical investigators in oncology to work at the interface of
laboratory science, clinical medicine, and population science. The DF/HCC K12 was first funded in 2002 and
has supported 23 Scholars, with an additional 12 Scholars who received 2 years of support through a Federal
Share mechanism. The Program emphasizes research training in molecular oncology and its application to
clinical medicine. The 18 K12-funded Scholars who completed participation have been exceptionally
successful, with an output of 564 publications, 77 grants, and all Scholars progressing to independent faculty
positions. We propose the renewal of this K12 to continue training clinicians from diverse disciplines, including
adult hematology/oncology, pediatric hematology/oncology, and radiation oncology to design and conduct
hypothesis-driven clinical oncology trials. To enhance our highly successful K12 program, we propose the
following Specific Aims:
Aim 1: We will recruit and select a diverse group of K12 Scholars. We will issue an annual Request for
Applications (RFA) using a variety of mechanisms to reach the widest possible audience of candidates. We
will aggressively promote the participation of women and other groups traditionally under-represented in
medicine. Eligible candidates come from a large and highly qualified pool, including senior fellows and junior
faculty within Dana Farber/Harvard Cancer Consortium (DF/HCC) institutions who have completed
subspecialty clinical training. Non-clinician postdoctoral researchers are not eligible for participation. An
Internal Advisory Committee (IAC), comprised of 20 DF/HCC faculty members with leadership roles and
established track records in original research and mentoring, will assist Program Leadership with Scholar
selection. We request a continuation of support for five Scholars per year with five year appointments.
Aim 2: We will provide a program of rigorous didactic training, career development, and mentored
clinical oncology research. Each Scholar will be guided by two Faculty Mentors, one for laboratory (or data
science) training, and one for clinical investigation. A group of 34 highly qualified and motivated Faculty
Mentors have been identified, but Scholars may elect to include additional mentors from the pool of >1,100
investigators within the seven DF/HCC institutions, as well as faculty from the Koch Institute at MIT and the
Broad Institute of Harvard and MIT. An individualized career development plan will be devised that includes
components of required and optional didactic training, hands-on laboratory research, and development of a
clinical trial. Scholars will share results and participate in networking activities at an annual retreat.
Aim 3: We w...

## Key facts

- **NIH application ID:** 9895629
- **Project number:** 5K12CA087723-18
- **Recipient organization:** MASSACHUSETTS GENERAL HOSPITAL
- **Principal Investigator:** BRUCE ALLAN CHABNER
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $959,799
- **Award type:** 5
- **Project period:** 2002-09-27 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9895629

## Citation

> US National Institutes of Health, RePORTER application 9895629, Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology (5K12CA087723-18). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/9895629. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*